Grant Tarsus Pharmaceuticals, Inc. Transaction History
Grant
- $170 Million
- Q1 2025
A detailed history of Grant transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Grant holds 13,156 shares of TARS stock, worth $631,488. This represents 0.4% of its overall portfolio holdings.
Number of Shares
13,156
Previous 39,299
66.52%
Holding current value
$631,488
Previous $2.18 Million
68.97%
% of portfolio
0.4%
Previous 1.22%
Shares
6 transactions
Others Institutions Holding TARS
# of Institutions
199Shares Held
40.1MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$157 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$155 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$122 Million5.35% of portfolio
-
Jennison Associates LLC2.49MShares$120 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$108 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.28B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...